Comparing different adjuvants for COVID-19 vaccines
Adjuvant Comparison and Characterization
This study is looking at how different ingredients can make COVID-19 vaccines work better, and it’s for anyone interested in improving vaccine effectiveness to help protect against the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11196783 on NIH RePORTER |
What this research studies
This research investigates how various adjuvants can enhance the effectiveness of COVID-19 vaccines by comparing their performance alongside different vaccine platforms. It aims to create detailed immunological profiles, known as 'immune fingerprints', that reveal how these adjuvants function in the body. By analyzing both systemic and tissue-specific immune responses, the study seeks to identify the best combinations for improving vaccine efficacy against SARS-CoV-2. Patients may benefit from insights that lead to more effective vaccination strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who are receiving or have received COVID-19 vaccinations and are interested in understanding how different adjuvants may enhance their immune response.
Not a fit: Patients who are not receiving COVID-19 vaccinations or those with contraindications to vaccines may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective COVID-19 vaccines that provide better protection against the virus.
How similar studies have performed: Previous research has shown promising results in enhancing vaccine efficacy through the use of different adjuvants, indicating that this approach has potential for success.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Pulendran, Bali — Stanford University
- Study coordinator: Pulendran, Bali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.